Author:
Balin-Gauthier Diane,Delord Jean-Pierre,Rochaix Philippe,Mallard Valérie,Thomas Fabienne,Hennebelle Isabelle,Bugat Roland,Canal Pierre,Allal Cuider
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference28 articles.
1. Arnould S, Hennebelle I, Canal P, Bugat R, Guichard S (2003) Cellular determinants of oxaliplatin sensitivity in colon cancer cell lines. Eur J Cancer 39:112–119
2. Bancroft CC, Chen Z, Yeh J, et al (2002) Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-KappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines. Int J Cancer 99:538–548
3. Baselga J, Norton L, Masui H, Pandiella A, Coplan K, Miller WH, Mendelsohn J (1993) Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies. J Natl Cancer Inst 85:1327–1333
4. Bleiberg H (1998) Oxaliplatin: a new reality in colorectal cancer. Br J Cancer 77(Suppl 4):1S–3S
5. Bruns CJ, Harbison MT, Davis DW et al (2000) Epidermal growth factor receptor blockade with cetuximab plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms. Clin Cancer Res 6:1936–1948
Cited by
79 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献